Active Research Support

National

Investigator: Thomas F. Patterson
Source: NIH/NIAID— NO1-AI-30041
Title: New Animal Models for Invasive Aspergillosis
Period: 8/15/03-8/14/10

Investigator: John F. Graybill
Role: Principal Investigator
Source: NIH/NIAID NO1-AI-25475
Title: Drug Development for Opportunistic Infections: Cryptococcus neoformans
Period: 6/28/02-6/27/09

Investigator: Thomas F. Patterson
Role: Principal investigator
Source: NIH/NIDCR 2 RO1-DE11381-04
Title: Fluconazole Resistance in Oropharyngeal Candidiasis
Period: 2000-2005

Investigator: Thomas F. Patterson
Role: Principal investigator
Source: NIH/NIDCR R21-DE015079
Title: Analysis of the Candida albicans Proteome
Period: 8/1/03-5/31/05

Investigator: Brian A. Wickes
Role: Principal Investigator
Source: National Institute of Allergy and Infectious Disease 1R01AI54946-01
Period: 2/03-1/06
Title: Congenic strains from serotype A Cryptococcus neoformans

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: NIH/NIAID R03 AI 054447
Title: NRG1 regulation of Candida albicans virulence
Dates: 04/01/2003 to 03/31/2005

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: NIH/NIDCR R21 DE 15079
Title: Analysis of the Candida albicans proteome
Dates: 08/01/2003 to 07/31/2005

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: Burroughs Wellcome Fund New Investigator in Molecular Mycology
Title: Gene and Protein Expression Profiling in Candida albicans biofilms
Dates: 07/2001-06/2004

Investigator: Yeh, C-K
Role: Principal Investigator
Agency: NIDCR R21(DE15381)
Title: Salivary Stem Cell Identification for Tissue Restoration
Period: 09/01/03 – 8/30/05

 Investigator: Yeh, C-K
Role: Principal Investigator
Title: Cellular signals in isoproterenol induced salivary cell growth
Role: Principal Investigator
Source: Veterans Administration Merit Review
Dates: 01/01/04 – 12/30/07

State/Local:

Investigator: Teresa Quitugua
Role: Co-Primary Investigator
Source: San Antonio Life Sciences Institute
Title: Immunization Against Coccidiodomycosis by Sindbis viruses Expressing Coccidioides Antigens
Dates: 2004-2006

 Investigator: Teresa Quitugua
Role: Primary Investigator
Source: UTHSCSA Institutional Research Grant
Title: Comparative utility of novel SSR analysis to current methods of Mycobacterium tuberculosis strain discrimination
Dates: 2003-2004

Investigator: Teresa Quitugua
Role: Primary Investigator
Source: San Antonio Area Foundation
Title: Multi-Locus VNTR analyses for Molecular Epidemiologic Studies of Tuberculosis
Dates: 2003-2004

Investigator: Teresa Quitugua
Role: Co-Investigator
Agency: Texas Higher Education Coordinating Board
Advanced Research/Advanced Technology Program
Title: Rapid Detection of Drug Resistant Mycobacterium tuberculosis using Two-Dimensional Gene Scanning
Years: 2002-2004

Investigator: Teresa N. Quitugua
Role: Principal Investigator
Source: National Institute of Allergy and Infectious Disease 1 RO1 AI058053-01
Title: Genotyping of Mycobacterium tuberculosis using SSRs
Dates: 03/01/05 – 02/28/08

Other:

Investigator: Thomas F. Patterson
Role: Principal Investigator
Source: Merck
Title: Efficacy and Safety of Caspofungin in a Real World Setting
Period: 2002-2004

Investigator: Thomas F. Patterson
Role: Principal Investigator
Source: Pfizer
Title: Efficacy of Voriconazole Alone and in Combination with Micafungin in a Guinea Pig Model of Invasive Aspergillosis
Period: 2002-2003

Source: McNeil, Inc.
Title: A Double Blind Randomized Vehicle Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% in Subjects with Radiation Induced Oral Mucositis
Dates: 2003-2004

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Ortho-Biotech, Inc.
Title: Antifungal suceptibility testing
Dates: 1/1/00-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Pfizer Inc.
Title: Antifungal suceptibility testing
Dates: 1/1/85-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Schering-Plough Research Laboratories
Title: Antifungal suceptibility testing
Dates: 1/1/99-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Bertek Pharmaceuticals, Inc.
Title: Yearly contract to evaluate antidermatophytic drugs
Dates: 1/1/96-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Merck & Co., Inc
Title: In vitro evaluation of caspofungin and standardization of in vitro testing methodology
Dates: 1/1/00-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Novartis Pharmaceuticals Corp.
Title: In vitro evaluation of antidermatophytic antifungal drugs
Dates: 1/1/99-present

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: Inhibitex, Inc.
Title: Development of Immune-Based Strategies against Candidiasis
Dates: 1/09/02-1/31/05

Investigator: John R. Graybill
Role: Principal Investigator
Source: Schering Plough Research Institute
Title: A Retrospective Study to Estabish an Historical Database on the Efficacy of Standard Antifungal Therapy in Patients with Invasive Fungal Infection. (PO2387-19)
Dates: 09/01/02 - Completion

Investigator: Spencer W. Redding
Role: Principal Investigator
Source: McNeil, Inc.
Title: A Double Blind Randomized Vehicle Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% in Subjects with Radiation Induced Oral Mucositis
Dates: 2003-2004